Pharmaceutical Industry

The “Pharmaceutical Industry” category at AssurX focuses on addressing challenges and opportunities within the sector. This section provides insights into quality management, regulatory compliance, and process optimization for drug development and manufacturing. It emphasizes ensuring product safety and efficacy. Discover strategies to navigate complex regulations and enhance operational efficiency. AssurX offers tools and knowledge to help pharmaceutical professionals maintain compliance, improve quality, and drive innovation.

24 04, 2018

Visit AssurX at the ASQ World Conference on Quality & Improvement (WCQI)

By |2024-07-01T22:17:54+00:00April 24th, 2018|Energy & Utilities Industry, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management|

AssurX, a leader in quality management software systems, will exhibit at the 201 [...]

14 03, 2018

Opinion: 3 Reasons to Consider SaaS for Quality Management Software

By |2018-03-14T13:49:08+00:00March 14th, 2018|FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management|

If you've been thinking about Software as a Service (SaaS) for your QMS and tryi [...]

11 04, 2017

Successful QMS Implementation Requires Clearly Defined Processes

By |2025-07-16T18:23:16+00:00April 11th, 2017|Archives, eMDR, FDA Regulated Industries, Food & Beverage Industry, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management|

Industry-leading quality management systems (QMS) are built with clearly defined [...]

10 04, 2017

China Addresses Life Sciences Regulatory Compliance Concerns

By |2017-04-10T13:44:24+00:00April 10th, 2017|Archives, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management, Risk Management|

China has often faced criticism for lax regulation of drug and medical device ma [...]

3 04, 2017

FDA Warning Letters Emphasize Document Control System Compliance

By |2025-04-03T01:32:10+00:00April 3rd, 2017|Archives, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management, Risk Management|

First-quarter 2017 Food and Drug Administration (FDA) warning letters emphasize [...]

Go to Top